OncoMed Pharmaceuticals negotiates $22.25 million placement of shares

Company sells 1,470,588 common shares at $15.13 per share to Celgene

By Devika Patel

Knoxville, Tenn., Dec. 3 - OncoMed Pharmaceuticals, Inc. arranged a $22.25 million private placement of stock with Celgene Corp. on Dec. 2, according to an 8-K filed Tuesday with the Securities and Exchange Commission.

The company will sell 1,470,588 common shares at $15.13 per share. The price per share reflects a 12.41% premium to the Nov. 29 closing share price of $13.46.

The biopharmaceutical company is based in Redwood City, Calif.

Issuer:	OncoMed Pharmaceuticals, Inc.
Issue:	Common stock
Amount:	$22,249,996
Shares:	1,470,588
Price:	$15.13
Warrants:	No
Investor:	Celgene Corp.
Pricing date:	Dec. 2
Stock symbol:	Nasdaq: OMED
Stock price:	$13.46 at close Nov. 29
Market capitalization:	$732.37 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.